Similar articles

• Factors affecting solubilized dopamine-sensitive adenylate cyclase.

  Marshall AM, Ramwani J, Mishra RK. Marshall AM, et al. Biochem Pharmacol. 1983 Apr 1;32(7):1237-41. doi: 10.1016/0006-2952(83)90277-0. Biochem Pharmacol. 1983. PMID: 6847713
• Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.

  Roufogalis BD, Thornton M, Wade DN. Roufogalis BD, et al. Life Sci. 1976 Sep 15;19(6):927-34. doi: 10.1016/0024-3205(76)90321-0. Life Sci. 1976. PMID: 966971 No abstract available.
• Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.

  Rotrosen J, Friedman E, Gershon S. Rotrosen J, et al. Life Sci. 1975 Aug 15;17(4):563-8. doi: 10.1016/0024-3205(75)90091-0. Life Sci. 1975. PMID: 171534 No abstract available.
• Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.

  Bockaert J, Tassin JP, Thierry AM, Glowinski J, Premont J. Bockaert J, et al. Brain Res. 1977 Feb 11;122(1):71-86. doi: 10.1016/0006-8993(77)90663-1. Brain Res. 1977. PMID: 837225
• Effect of methadone and dextromoramide on dopamine metabolism: comparison with haloperidol and amphetamine.

  Gessa GL, Tagliamonte A. Gessa GL, et al. Neuropharmacology. 1975 Dec;14(12):913-20. doi: 10.1016/0028-3908(75)90045-3. Neuropharmacology. 1975. PMID: 768800 Review. No abstract available.